Jefferies Maintains Amicus Therapeutics(FOLD.US) With Buy Rating, Maintains Target Price $18

Futu NewsDec 17 21:31 · Ratings

Morgan Stanley Upgrades PTC, Cuts Immuneering, Amicus

Seeking AlphaDec 14 03:42

Why Are Amicus, Immunocore, & Immuneering Stocks Trading Lower On Friday?

BenzingaDec 14 03:10

Amicus Therapeutics (FOLD) Is a Top-Ranked Momentum Stock: Should You Buy?

Yahoo FinanceDec 13 22:50

Amicus Therapeutics Cut to Equal-Weight From Overweight by Morgan Stanley

Dow JonesDec 13 20:08 · Ratings

Morgan Stanley Downgrades Amicus Therapeutics(FOLD.US) to Hold Rating, Cuts Target Price to $12

Futu NewsDec 13 09:32 · Ratings